Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
© 2021. The Author(s), under exclusive licence to CSI and USTC..
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection induces an exacerbated inflammation driven by innate immunity components. Dendritic cells (DCs) play a key role in the defense against viral infections, for instance plasmacytoid DCs (pDCs), have the capacity to produce vast amounts of interferon-alpha (IFN-α). In COVID-19 there is a deficit in DC numbers and IFN-α production, which has been associated with disease severity. In this work, we described that in addition to the DC deficiency, several DC activation and homing markers were altered in acute COVID-19 patients, which were associated with multiple inflammatory markers. Remarkably, previously hospitalized and nonhospitalized patients remained with decreased numbers of CD1c+ myeloid DCs and pDCs seven months after SARS-CoV-2 infection. Moreover, the expression of DC markers such as CD86 and CD4 were only restored in previously nonhospitalized patients, while no restoration of integrin β7 and indoleamine 2,3-dyoxigenase (IDO) levels were observed. These findings contribute to a better understanding of the immunological sequelae of COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Cellular & molecular immunology - 18(2021), 9 vom: 21. Sept., Seite 2128-2139 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 21.09.2021 Date Revised 17.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41423-021-00728-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328353906 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328353906 | ||
| 003 | DE-627 | ||
| 005 | 20231225202747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41423-021-00728-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1094.xml |
| 035 | |a (DE-627)NLM328353906 | ||
| 035 | |a (NLM)34290398 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pérez-Gómez, Alberto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.09.2021 | ||
| 500 | |a Date Revised 17.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s), under exclusive licence to CSI and USTC. | ||
| 520 | |a Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection induces an exacerbated inflammation driven by innate immunity components. Dendritic cells (DCs) play a key role in the defense against viral infections, for instance plasmacytoid DCs (pDCs), have the capacity to produce vast amounts of interferon-alpha (IFN-α). In COVID-19 there is a deficit in DC numbers and IFN-α production, which has been associated with disease severity. In this work, we described that in addition to the DC deficiency, several DC activation and homing markers were altered in acute COVID-19 patients, which were associated with multiple inflammatory markers. Remarkably, previously hospitalized and nonhospitalized patients remained with decreased numbers of CD1c+ myeloid DCs and pDCs seven months after SARS-CoV-2 infection. Moreover, the expression of DC markers such as CD86 and CD4 were only restored in previously nonhospitalized patients, while no restoration of integrin β7 and indoleamine 2,3-dyoxigenase (IDO) levels were observed. These findings contribute to a better understanding of the immunological sequelae of COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Dendritic cell | |
| 650 | 4 | |a Long-COVID | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 7 | |a Interferon-alpha |2 NLM | |
| 700 | 1 | |a Vitallé, Joana |e verfasserin |4 aut | |
| 700 | 1 | |a Gasca-Capote, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Gutierrez-Valencia, Alicia |e verfasserin |4 aut | |
| 700 | 1 | |a Trujillo-Rodriguez, María |e verfasserin |4 aut | |
| 700 | 1 | |a Serna-Gallego, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz-Muela, Esperanza |e verfasserin |4 aut | |
| 700 | 1 | |a Jiménez-Leon, María de Los Reyes |e verfasserin |4 aut | |
| 700 | 1 | |a Rafii-El-Idrissi Benhnia, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Rivas-Jeremias, Inmaculada |e verfasserin |4 aut | |
| 700 | 1 | |a Sotomayor, Cesar |e verfasserin |4 aut | |
| 700 | 1 | |a Roca-Oporto, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Espinosa, Nuria |e verfasserin |4 aut | |
| 700 | 1 | |a Infante-Domínguez, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Crespo-Rivas, Juan Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Villar, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-González, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a López-Cortés, Luis Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a Poveda, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz-Mateos, Ezequiel |e verfasserin |4 aut | |
| 700 | 0 | |a Virgen del Rocío Hospital COVID-19 Working Team |e verfasserin |4 aut | |
| 700 | 1 | |a Cisneros, José Miguel |e investigator |4 oth | |
| 700 | 1 | |a Salto-Alejandre, Sonsoles |e investigator |4 oth | |
| 700 | 1 | |a Berastegui-Cabrera, Judith |e investigator |4 oth | |
| 700 | 1 | |a Camacho-Martínez, Pedro |e investigator |4 oth | |
| 700 | 1 | |a Infante-Domínguez, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Carretero-Ledesma, Marta |e investigator |4 oth | |
| 700 | 1 | |a Crespo-Rivas, Juan Carlos |e investigator |4 oth | |
| 700 | 1 | |a Márquez, Eduardo |e investigator |4 oth | |
| 700 | 1 | |a Lomas, José Manuel |e investigator |4 oth | |
| 700 | 1 | |a Bueno, Claudio |e investigator |4 oth | |
| 700 | 1 | |a Amaya, Rosario |e investigator |4 oth | |
| 700 | 1 | |a Lepe, José Antonio |e investigator |4 oth | |
| 700 | 1 | |a Pachón, Jerónimo |e investigator |4 oth | |
| 700 | 1 | |a Cordero, Elisa |e investigator |4 oth | |
| 700 | 1 | |a Sánchez-Céspedes, Javier |e investigator |4 oth | |
| 700 | 1 | |a Aguilar-Guisado, Manuela |e investigator |4 oth | |
| 700 | 1 | |a Aguilera, Almudena |e investigator |4 oth | |
| 700 | 1 | |a Aguilera, Clara |e investigator |4 oth | |
| 700 | 1 | |a Aldabo-Pallas, Teresa |e investigator |4 oth | |
| 700 | 1 | |a Alfaro-Lara, Verónica |e investigator |4 oth | |
| 700 | 1 | |a Amodeo, Cristina |e investigator |4 oth | |
| 700 | 1 | |a Ampuero, Javier |e investigator |4 oth | |
| 700 | 1 | |a Avilés, María Dolores |e investigator |4 oth | |
| 700 | 1 | |a Asensio, Maribel |e investigator |4 oth | |
| 700 | 1 | |a Barón-Franco, Bosco |e investigator |4 oth | |
| 700 | 1 | |a Barrera-Pulido, Lydia |e investigator |4 oth | |
| 700 | 1 | |a Bellido-Alba, Rafael |e investigator |4 oth | |
| 700 | 1 | |a Bernabeu-Wittel, Máximo |e investigator |4 oth | |
| 700 | 1 | |a Caballero-Eraso, Candela |e investigator |4 oth | |
| 700 | 1 | |a Cabrera, Macarena |e investigator |4 oth | |
| 700 | 1 | |a Calderón, Enrique |e investigator |4 oth | |
| 700 | 1 | |a Carbajal-Guerrero, Jesús |e investigator |4 oth | |
| 700 | 1 | |a Cid-Cumplido, Manuela |e investigator |4 oth | |
| 700 | 1 | |a Corcia-Palomo, Yael |e investigator |4 oth | |
| 700 | 1 | |a Delgado, Juan |e investigator |4 oth | |
| 700 | 1 | |a Domínguez-Petit, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Deniz, Alejandro |e investigator |4 oth | |
| 700 | 1 | |a Dusseck-Brutus, Reginal |e investigator |4 oth | |
| 700 | 1 | |a Escoresca-Ortega, Ana |e investigator |4 oth | |
| 700 | 1 | |a Espinosa, Fátima |e investigator |4 oth | |
| 700 | 1 | |a Espinosa, Nuria |e investigator |4 oth | |
| 700 | 1 | |a Espinoza, Michelle |e investigator |4 oth | |
| 700 | 1 | |a Ferrándiz-Millón, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Ferrer, Marta |e investigator |4 oth | |
| 700 | 1 | |a Ferrer, Teresa |e investigator |4 oth | |
| 700 | 1 | |a Gallego-Texeira, Ignacio |e investigator |4 oth | |
| 700 | 1 | |a Gámez-Mancera, Rosa |e investigator |4 oth | |
| 700 | 1 | |a García, Emilio |e investigator |4 oth | |
| 700 | 1 | |a García-Delgado, Horacio |e investigator |4 oth | |
| 700 | 1 | |a García-Gutiérrez, Manuel |e investigator |4 oth | |
| 700 | 1 | |a Gascón-Castillo, María Luisa |e investigator |4 oth | |
| 700 | 1 | |a González-Estrada, Aurora |e investigator |4 oth | |
| 700 | 1 | |a González, Demetrio |e investigator |4 oth | |
| 700 | 1 | |a Gómez-González, Carmen |e investigator |4 oth | |
| 700 | 1 | |a González-León, Rocío |e investigator |4 oth | |
| 700 | 1 | |a Grande-Cabrerizo, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Gutiérrez, Sonia |e investigator |4 oth | |
| 700 | 1 | |a Hernández-Quiles, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Herrera-Melero, Inmaculada Concepción |e investigator |4 oth | |
| 700 | 1 | |a Herrero-Romero, Marta |e investigator |4 oth | |
| 700 | 1 | |a Jara, Luis |e investigator |4 oth | |
| 700 | 1 | |a Jiménez-Juan, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Jiménez-Jorge, Silvia |e investigator |4 oth | |
| 700 | 1 | |a Jiménez-Sánchez, Mercedes |e investigator |4 oth | |
| 700 | 1 | |a Lanseros-Tenllado, Julia |e investigator |4 oth | |
| 700 | 1 | |a López, Carmina |e investigator |4 oth | |
| 700 | 1 | |a López, Isabel |e investigator |4 oth | |
| 700 | 1 | |a López-Barrios, Álvaro |e investigator |4 oth | |
| 700 | 1 | |a López-Cortés, Luis F |e investigator |4 oth | |
| 700 | 1 | |a Luque-Márquez, Rafael |e investigator |4 oth | |
| 700 | 1 | |a Macías-García, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Martín-Gutiérrez, Guillermo |e investigator |4 oth | |
| 700 | 1 | |a Martín-Villén, Luis |e investigator |4 oth | |
| 700 | 1 | |a Molina, José |e investigator |4 oth | |
| 700 | 1 | |a Morillo, Aurora |e investigator |4 oth | |
| 700 | 1 | |a Navarro-Amuedo, María Dolores |e investigator |4 oth | |
| 700 | 1 | |a Nieto-Martín, Dolores |e investigator |4 oth | |
| 700 | 1 | |a Ortega, Francisco |e investigator |4 oth | |
| 700 | 1 | |a Paniagua-García, María |e investigator |4 oth | |
| 700 | 1 | |a Peña-Rodríguez, Amelia |e investigator |4 oth | |
| 700 | 1 | |a Pérez, Esther |e investigator |4 oth | |
| 700 | 1 | |a Poyato, Manuel |e investigator |4 oth | |
| 700 | 1 | |a Praena-Segovia, Julia |e investigator |4 oth | |
| 700 | 1 | |a Ríos, Rafaela |e investigator |4 oth | |
| 700 | 1 | |a Roca-Oporto, Cristina |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez, Jesús F |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez-Hernández, María Jesús |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez-Suárez, Santiago |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez-Villodres, Ángel |e investigator |4 oth | |
| 700 | 1 | |a Romero-Rodríguez, Nieves |e investigator |4 oth | |
| 700 | 1 | |a Ruiz, Ricardo |e investigator |4 oth | |
| 700 | 1 | |a de Azua, Zida Ruiz |e investigator |4 oth | |
| 700 | 1 | |a Salamanca, Celia |e investigator |4 oth | |
| 700 | 1 | |a Sánchez, Sonia |e investigator |4 oth | |
| 700 | 1 | |a Sánchez-Montagut, Víctor Manuel |e investigator |4 oth | |
| 700 | 1 | |a Sotomayor, César |e investigator |4 oth | |
| 700 | 1 | |a Benjumea, Alejandro Suárez |e investigator |4 oth | |
| 700 | 1 | |a Toral, Javier |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Cellular & molecular immunology |d 2004 |g 18(2021), 9 vom: 21. Sept., Seite 2128-2139 |w (DE-627)NLM158038010 |x 2042-0226 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2021 |g number:9 |g day:21 |g month:09 |g pages:2128-2139 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41423-021-00728-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2021 |e 9 |b 21 |c 09 |h 2128-2139 | ||